These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34097101)

  • 21. Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.
    Sgouropoulou V; Stabouli S; Trachana M
    Clin Rheumatol; 2019 Sep; 38(9):2577-2584. PubMed ID: 31127463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B; Kasapcopur O
    Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y; Gezer HH; Duruöz MT
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
    Erten S; Erten SF; Altunoglu A
    Rheumatol Int; 2012 Apr; 32(4):1095-7. PubMed ID: 21431291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Drosos AA; Pelechas E; Drossou V; Voulgari PV
    Rheumatol Ther; 2022 Apr; 9(2):379-389. PubMed ID: 35107804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey.
    Kavrul Kayaalp G; Sozeri B; Sönmez HE; Demir F; Cakan M; Oztürk K; Karadag SG; Otar Yener G; Ozdel S; Baglan E; Celikel E; Sahin N; Gezgin Yildirim D; Eker Omeroglu R; Aktay Ayaz N;
    Rheumatol Int; 2022 Jan; 42(1):87-94. PubMed ID: 33454820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].
    Kallinich T; Blank N; Braun T; Feist E; Kiltz U; Neudorf U; Oommen PT; Weseloh C; Wittkowski H; Braun J
    Z Rheumatol; 2019 Feb; 78(1):91-101. PubMed ID: 30684030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L; Marchetti F; Tommasini A; Ventura A
    Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
    Ozkan S; Atas B
    J Pak Med Assoc; 2017 Jun; 67(6):945-947. PubMed ID: 28585601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine: 1998 update.
    Ben-Chetrit E; Levy M
    Semin Arthritis Rheum; 1998 Aug; 28(1):48-59. PubMed ID: 9726336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
    J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance.
    Erden A; Batu ED; Armagan B; Sönmez HE; Sarı A; Demir S; Bilgin E; Fırat E; Kılıc L; Bilginer Y; Karadag O; Kiraz S; Kalyoncu U
    Biomark Med; 2018 Jun; 12(6):565-572. PubMed ID: 29873519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.
    Haj Yahia S; Ben Zvi I; Livneh A
    Rheumatol Int; 2018 Jan; 38(1):141-147. PubMed ID: 28975396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.
    Sag E; Akal F; Atalay E; Akca UK; Demir S; Demirel D; Batu ED; Bilginer Y; Ozen S
    Rheumatology (Oxford); 2020 Nov; 59(11):3324-3329. PubMed ID: 32306038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder?
    Aldea A; Campistol JM; Arostegui JI; Rius J; Maso M; Vives J; Yagüe J
    Am J Med Genet A; 2004 Jan; 124A(1):67-73. PubMed ID: 14679589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases?
    Ben-Chetrit E; Levy M
    Med Hypotheses; 1998 Nov; 51(5):377-80. PubMed ID: 9848464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.